X

Infection/Disease

New £18m gene therapy centre will ‘cure the incurable’

A new dedicated gene therapy hub for the North of England will fast-track treatments for diseases and conditions which are…

New molecular mechanisms identified in dermatitis

New molecular mechanisms identified in chronic skin inflammation:Frequently occurring chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and…

How coronavirus spreads through air

Samples from public spaces could show how coronavirus spreads through the air: A new UK study will explore whether tiny…

Severe COVID-19 risk factors

Severe COVID-19 risk factors: The course and severity of COVID-19 in individual patients is largely influenced by the interaction between…

The unusual suspects: Rare disease webinar

The unusual suspects: Rare disease in everyday medicine from The Royal Society of Medicine. Date and time: Wed 24 Feb…

Monday 22 February is World Encephalitis Day

World Encephalitis Day is the global awareness day for people who have been directly or indirectly affected by encephalitis. Founded by…

How inflammatory signalling molecules contribute to carcinogenesis

How inflammatory signalling molecules contribute to carcinogenesis: A team of MedUni Vienna researchers led by Johannes A. Schmid at the…

When the time comes

Families of older people dying of progressive chronic disease often feel insufficiently informed about the course of the illness, so…

Resurgence of Ebola in Butembo, North Kivu DRC

Resurgence of Ebola in Butembo, North Kivu in the Democratic Republic of the Congo: Brazzaville – The Ministry of Health of the…

New drug development using Nature’s strategies

Oxytocin/vasopressin receptors are typical examples of so-called G protein-coupled receptors – the most successful drug target class. The oxytocin and…

This website uses cookies.